BusinessAXIM Biotech to Attend Biocentury’s 24th Annual Future Leaders in the Biotech Industry Conference in New YorkBy Nasdaq OMXApr 5, 2017, 1:01 PM UTC
BusinessAXIM Biotech Enters Term Sheet Agreement With US API Company to Develop Bioequivalent Product to MarinolBy Nasdaq OMXMar 28, 2017, 1:01 PM UTC
BusinessEarth Science Tech, Enters Multi-Billion Dollar Sports Supplement Industry via Joint Venture with Nutrition Specialties and ForzagenBy Nasdaq OMXJan 31, 2017, 12:45 PM UTC
BusinessEarth Science Tech, Inc. (OTC: ETST) Finalizes Joint Venture with Karmavore Superfoods and Signs New CMO, Sergio CastilloBy Nasdaq OMXJan 25, 2017, 12:45 PM UTC
BusinessEarth Science Tech, Inc. (OTC: ETST) Signs Marketing & Media Agreement with Pearls of Health and Appoints Gabriel Aviles as Chief Sales Officer (CSO).By Nasdaq OMXJan 9, 2017, 12:45 PM UTC
BusinessAXIM Biotech Begins PK/PD Studies With CanChew Plus CBD Gum for IBS Symptoms in Suffering PatientsBy Nasdaq OMXNov 1, 2016, 1:01 PM UTC
BusinessAXIM Biotech Begins PK/PD Studies With CanChew Plus CBD Gum for IBS Symptoms in Suffering PatientsBy Nasdaq OMXNov 1, 2016, 1:01 PM UTC
BusinessAXIM® Biotechnologies, Inc. Secures Funding to Continue Pharmaceutical Clinical Trials Program in Cannabinoid Research and Development for Multiple IndicationsBy Nasdaq OMXOct 26, 2016, 1:04 PM UTC
